Investing.com - Financial Markets Worldwide
Get 40% Off
Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

Gilead Sciences Inc (GILD)

NASDAQ
Symbol
Exchange
Currency
GILDNASDAQUSD
GILDMexicoMXN
GGILDMilanEUR
GILDXetraEUR
GILDFrankfurtEUR
GILDTradeGateEUR
GILDBuenos AiresARS
GILDViennaEUR
GILDLimaUSD
Currency in USD
Disclaimer
65.42
+0.15(+0.23%)
Closed
After Hours
65.50+0.08(+0.12%)

GILD Comments

https://invst.ly/tqicz
https://invst.ly/tr34y
https://invst.ly/tr4ab
I think we should see $84 by June this year, but I don’t think it’s going be higher until they start to get profits from new cancer drugs. Anyway, probably next year can be game changer for the stock.
Pfizer Drops India Vaccine Application After Regulator Seeks Local Trial - Reuters. I guess pfizer doesnt care about Indians well being... or the vacine is a fraud. Dont worry gilead gave them Veklury. Thanks but no thanks Pfizer.
when is the dividend date?
Guys and girls, what did I said? 2021 gonna be the beginning of strong moving year for Gilead, hop on the train now before it’s gonna be late.
EPS earning good!
$75 next week
The conference call is at 430pm but when is the earning release?
during the conference
Great news https://finance.yahoo.com/news/gilead-sciencess-earnings-outlook-151440708.html Remenber after earnings often stock flet but by the half of february the stock will reach 75 usd and dont forget MORGAN STANLEY 83 usd TARGET https://www.barrons.com/articles/2-reasons-this-will-be-gileads-year-says-morgan-stanley-51611082220
This is worse than watching KHC
lol, this stock sacks
Thank you Morgan Stanley to 83
Calm down guys. You gonna regret if you are selling. 2021 will be a good year. Just wait to the first earning and you will see the devellopment.
Sell it and run away, this is probably the last days we ever see this stock above 60
why do you think so?
Look how hopeless the 5y graps looks. And if the price falls below 57, then god knows where the bottom is. $30? $20? I wouldn’t want to risk.
why didn't you get in at $57.50-58.50 range, target 70-80 range and stop at 56.9? can you doing better that this risk rewards anywhere? anyways it's gone now. I am long in GILD and target is $75
GILD management team, WS wants to know your future, but you told them what you were in the past year. That won't work, grow up!
This is a good and fresh start for the new year🍸
OTC: RDGL     0.13 per share. On on before Jan 16 2021 the FDA will grant or deny emergency break through status on their drug.
ready to fly soon
ready to bounce back to 90s
Had limit orders for 55... think it will drop more or should I buy now?
maybe 50? 45?
wait 45
 Going to start DCAing small amounts at 5 intervals. I would wait but don't want to miss out on JPM conference results. Think it can bounce back with earnings/5% dividends and their drug pipeline is pretty good.
take a look: https://www.griproom.com/fun/it-looks-like-gilead-is-about-to-merge-with-roche
60+ coming
Bogged stonk
too much speculative capital entered here this year, old investors managed to sell on time, this opened the way to lower levels until speculators fix losses.
They donated too many doses and market reaction to other drugs in pipeline was overreaction. I think it's just bad stockholder confidence. They still have good drugs in pipeline and remdssivir is still relevant and drug of choice with steroids to reduce hospital stay.
Remdesivir is a rubbish drug.
...
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.